Australia’s clinical trials register is at risk of being exploited by clinics advertising “pretend” trials to solicit business for expensive unproven stem cell therapies. Academics including Sydney-based pathologist and haematologist Professor John Rasko and US bioethicist Dr Leigh Turner have warned of a worldwide trend in which clinics engaging in direct-to-market advertising of unproven stem ...
Australian clinical trial register vulnerable to exploitation
By Tessa Hoffman
22 Aug 2017